| Literature DB >> 10073910 |
J Poudrier1, F Lettre, M St-Louis, R M Tanguay.
Abstract
Tyrosinaemia type I is caused by a deficiency of fumarylacetoacetate hydrolase and mainly affects the liver. This disease is characterized by the presence of a high level of succinylacetone. This metabolite has been used for prenatal diagnosis from amniotic fluid samples. One case with a normal level of succinylacetone in amniotic fluid has recently been described (Grenier et al., 1996). Here, we report that this patient is a compound heterozygote for two known mutations: E364X and IVS6-1g-->t. The low level of succinylacetone cannot be explained by these mutations.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10073910 DOI: 10.1002/(sici)1097-0223(199901)19:1<61::aid-pd455>3.0.co;2-#
Source DB: PubMed Journal: Prenat Diagn ISSN: 0197-3851 Impact factor: 3.050